• News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • X (Twitter)
  • LinkedIn
Stock Screener·US·Consumer Cyclical·JRJRQ
Share

JRjr33, Inc. Stocks

$ 0Last Updated 23.10.2026

Issuer Rating

3/7
Performance

Favourable

Risk

Critical

Recommendation

Sell

Market Cap

$ 4484

$ 0
Key Takeaways

Risk factor

Critical default risk

Data is available to registered users only
Data is available to registered users only

Profitability factor

Greatly undervalued vs peers

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

Dallas, Texas-based JRjr33, Inc., which was previously known as CVSL Inc. until its renaming in March 2016, managed a collection of direct-to-consumer brands both within the United States and abroad. The company structured its operations into three primary divisions: home furnishings, health and wellness products, and specialty gourmet food. Its diverse product range encompassed artisan-crafted home goods like baskets, pottery, and decorative vinyl expressions; a variety of unique food items such as hand-blended spices, oils, and baking mixes; and health-centric offerings including nutritional supplements and skincare. Furthermore, JRjr33 distributed a monthly magazine and sold other merchandise, including stationery, personalized gifts, household items, and seasonal products. Sales were conducted directly to customers, through independent sales representatives, and via multiple channels such as online platforms, mail, and telephone. The company ultimately faced significant financial difficulties, filing for Chapter 11 bankruptcy on June 29, 2018, with its reorganization petition subsequently converted to Chapter 7 on October 26, 2018.

Company Valuation

Greatly undervalued
7/7

Considering past and projected metrics, the stock is distinctly 'cheaper' than its peers.

Data is available to registered users only
Sign up to access detailed valuation

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

Trending

24.10.2026 16:01

Highlights in Small-Cap Stocks: The Merck Deal, the Success of a Hair Loss Pill, and Braze's "Wow Factor"

24.10.2026 13:01

AI investors are already on the brink, a “French kiss” for the euro, and hackers at the gates

24.10.2026 05:04

Hedge funds have ramped up their bets against the euro to a 2020 high

24.10.2026 04:46

France Avoided a Downgrade by Moody’s After a Week of Crisis

24.10.2026 04:37

A key Novartis drug failed to meet expectations. The stock price fell

X-channel

Buy

Sell

0 more stocks

Company

  • About
  • Contributors
  • Contacts
  • Legal Information

Social media

  • X (Twitter)
  • LinkedIn

Services

  • Stock Screener
  • Guru Portfolios
  • X (Twitter)
  • LinkedIn
Oninvest© 2026